Canopy Growth (CGC) Net Income (2019 - 2026)
Canopy Growth (CGC) posted Net Income of -$3.6 million for Q3 2025, down 251.5% sequentially from $2.4 million in Q3 2024, and down 251.5% YoY from $2.4 million in Q3 2024.
Canopy Growth (CGC) Net Income (2019 - 2026) Analysis & Trends
Canopy Growth has reported Net Income for 7 years, with the latest figure at -$3.6 million in Q3 2025.
- Quarterly Net Income fell 251.5% year-over-year to -$3.6 million in Q3 2025, while the trailing twelve-month figure through Mar 2026 was -$3.6 million (down 193.02% YoY) and the FY2025 annual result came in at -$55.2 million, changed N/A from the prior year.
- Net Income retreated to -$3.6 million in Q3 2025 per CGC's latest filing, from $2.4 million in the prior quarter.
- Over five years, Net Income peaked at $317.2 million in Q2 2021 and troughed at -$1.6 billion in Q2 2022.
- A 5-year average of -$138.9 million and a median of -$25.5 million in 2022 frame the typical range for Net Income.
- The sharpest annual moves came in 2021 and 2022: Net Income surged 442.79% in 2021, then tumbled 617.16% in 2022.
- Over 5 years, Net Income stood at -$91.6 million in 2021, then surged by 69.82% to -$27.6 million in 2022, then jumped by 135.81% to $9.9 million in 2023, then slumped by 75.89% to $2.4 million in 2024, then plunged by 251.5% to -$3.6 million in 2025.
- According to Business Quant data, Net Income over the past three periods registered -$3.6 million, $2.4 million, and $1.5 million for Q3 2025, Q3 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | -69.36 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 144.40 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Canopy Growth | 437.04 Mn | 190.03 Mn | 16.08 Mn | -10.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -10.54 Mn |
| Sep 30, 2025 | -3.62 Mn |
| Sep 30, 2024 | 2.39 Mn |
| Jun 30, 2024 | 1.50 Mn |
| Mar 31, 2024 | 1.74 Mn |
| Dec 31, 2023 | 9.90 Mn |
| Sep 30, 2023 | -131.76 Mn |
| Jun 30, 2023 | -23.30 Mn |
| Mar 31, 2023 | -44.10 Mn |
| Dec 31, 2022 | -27.65 Mn |
| Sep 30, 2022 | -83.84 Mn |
| Jun 30, 2022 | -1.64 Bn |
| Mar 31, 2022 | -408.19 Mn |
| Dec 31, 2021 | -91.63 Mn |
| Sep 30, 2021 | -12.97 Mn |
| Jun 30, 2021 | 317.24 Mn |
| Mar 31, 2021 | -87.57 Mn |
| Dec 31, 2020 | -636.08 Mn |
| Sep 30, 2020 | -72.45 Mn |
| Jun 30, 2020 | -92.55 Mn |